96 related articles for article (PubMed ID: 2983433)
1. The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group.
Banham S; Dorward A; Hutcheon A; Ahmedzai S; Cunningham D; Burnett A; Soukop M; Lucie N; Kaye S
Semin Oncol; 1985 Mar; 12(1 Suppl 2):2-6. PubMed ID: 2983433
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Combination versus alternating chemotherapy in small-cell lung cancer.
Lai SL; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
[TBL] [Abstract][Full Text] [Related]
7. Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
Harper PG; Souhami RL; Spiro SG; Geddes DM; Guimaraes M; Fearon F; Smyth JF
Cancer Treat Rep; 1982 Mar; 66(3):463-70. PubMed ID: 6277486
[TBL] [Abstract][Full Text] [Related]
8. High-dose etoposide (VP-16) in small-cell lung cancer.
Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
[TBL] [Abstract][Full Text] [Related]
9. Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
Messeih AA; Schweitzer JM; Lipton A; Harvey HA; Simmonds MA; Stryker JA; Ricci JA; Hoffman SL; Gottleib RJ; Dixon RH
Cancer Treat Rep; 1987 Jan; 71(1):61-6. PubMed ID: 3024828
[TBL] [Abstract][Full Text] [Related]
10. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
11. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
12. Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung.
Abeloff MD; Ettinger DS; Order SE; Khouri N; Mellits ED; Dorschel NT; Baumgardner R
Cancer Treat Rep; 1981; 65(7-8):639-46. PubMed ID: 6265082
[TBL] [Abstract][Full Text] [Related]
13. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
Behera D; Jindal SK; Sharma SC
Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
[TBL] [Abstract][Full Text] [Related]
14. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
15. Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Wolff SN; Birch R; Sarma P; Greco FA
Cancer Treat Rep; 1986 May; 70(5):583-7. PubMed ID: 3011257
[TBL] [Abstract][Full Text] [Related]
16. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
18. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy for small cell lung cancer.
Sufarlan AW; Zainudin BM
Med J Malaysia; 1993 Jun; 48(2):166-70. PubMed ID: 8394502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]